Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita ™ System in Subjects With Type 2 Diabetes on Insulin Therapy
Conditions: Type 2 Diabetes; NASH - Nonalcoholic Steatohepatitis; NAFLD Interventions: Device: Duodenal Mucosal Resurfacing (DMR) Procedure; Device: Sham Sponsor: Fractyl Laboratories, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Non-alcoholic Fatty Liver Diseases (NAFLD) | Research